Solid Biosciences (SLDB) Assets: 2017-2023
Historic Assets for Solid Biosciences (SLDB) over the last 7 years, with Dec 2023 value amounting to $164.9 million.
- Solid Biosciences' Assets rose 14.67% to $211.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $211.8 million, marking a year-over-year increase of 14.67%. This contributed to the annual value of $164.9 million for FY2023, which is 36.62% down from last year.
- Solid Biosciences' Assets amounted to $164.9 million in FY2023, which was down 36.62% from $260.3 million recorded in FY2022.
- Solid Biosciences' 5-year Assets high stood at $260.3 million for FY2022, and its period low was $103.5 million during FY2019.
- Its 3-year average for Assets is $219.2 million, with a median of $232.4 million in 2021.
- Per our database at Business Quant, Solid Biosciences' Assets surged by 65.43% in 2020 and then slumped by 36.62% in 2023.
- Solid Biosciences' Assets (Yearly) stood at $103.5 million in 2019, then surged by 65.43% to $171.2 million in 2020, then soared by 35.76% to $232.4 million in 2021, then grew by 11.99% to $260.3 million in 2022, then plummeted by 36.62% to $164.9 million in 2023.